| Report ID |
125057 |
| Drug Identification Number |
02212188 |
| Brand name |
IMITREX |
| Common or Proper name |
Sumatriptan succinate injection |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
SUMATRIPTAN |
| Strength(s) |
6MG |
| Dosage form(s) |
LIQUID |
| Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
| Packaging size |
2x0.5mL |
| ATC code |
N02CC |
| ATC description |
ANTIMIGRAINE PREPARATIONS |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
|
| Actual start date |
2020-09-24 |
| Estimated end date |
2020-10-14 |
| Actual end date |
2020-10-05 |
| Shortage status |
Resolved |
| Updated date |
2020-10-08 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
1-800-387-7374 |
